Fibrinogen Binding Inhibitor Peptide is primarily used in medical research and therapeutic applications to prevent the binding of fibrinogen to platelets. This inhibition is crucial in studies related to blood clot formation and cardiovascular diseases. By blocking this interaction, the peptide helps in understanding the mechanisms of thrombosis and can be a potential candidate for developing antithrombotic drugs. Additionally, it is utilized in experimental models to investigate inflammatory responses and wound healing processes, as fibrinogen plays a significant role in these pathways. Its application extends to the development of targeted therapies for conditions where abnormal clot formation is a concern, such as in stroke or myocardial infarction.